Related Experiment Video
Updated: Jun 2, 2026
10:29
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
Targeting regulatory T cells for anticancer therapy
G D'Arena1, S Deaglio, L Laurenti
1Hematology and Stem Cell Transplantation Unit, IRCCS Casa Sollievo della Sofferenza Hospital, Viale dei Cappuccini n.1, 71013 San Giovanni Rotondo (FG), Italy. giovannidarena@libero.it
Mini Reviews in Medicinal Chemistry
|May 13, 2011
Summary
Regulatory T-cells (Tregs) suppress immune responses and are found in tumors, aiding cancer evasion. Inhibiting Tregs could restore the body's ability to fight cancer, with new therapies in development.
Area of Science:
- Immunology
- Oncology
Background:
- Regulatory T-cells (Tregs) are CD4+ cells that suppress immune responses against self- and foreign-antigens.
- Increased Tregs in tumor tissues are implicated in cancer pathogenesis by enabling immune evasion.
Purpose of the Study:
- To explore the role of Tregs in cancer immune evasion.
- To review strategies for targeting tumor-associated Tregs to restore antitumor immunity.
Main Methods:
- Literature review on Treg function in cancer.
- Analysis of emerging therapeutic strategies targeting Tregs.
Main Results:
- Tregs contribute to tumor immune evasion.
- Depleting or inhibiting Tregs shows potential for restoring antitumor immunity.
Conclusions:
- Targeting tumor-associated Tregs is a promising strategy for cancer immunotherapy.
- Further research into Treg regulation is crucial for developing effective cancer treatments.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...